SOPHiA GENETICS (SOPH) Receivables (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Receivables data on file, last reported at $15.0 million in Q4 2025.

• For the quarter ending Q4 2025, Receivables rose 101.73% year-over-year to $15.0 million; the trailing twelve-month figure through Dec 2025 stood at $15.0 million (up 101.73% YoY), and the FY2025 full-year result was $15.0 million, up 101.73% from the prior year.
• Receivables grew to $15.0 million in Q4 2025, from $8.5 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $15.0 million in Q4 2025 to a low of $6.3 million in Q1 2022.
• A 5-year average of $9.1 million and a median of $9.5 million in 2025 frame the typical range for Receivables.
• Across the five-year window, Receivables jumped 103.9% in 2023 and plunged 45.15% in 2024, its largest moves.
• Tracing SOPH's Receivables over 5 years: stood at $7.1 million in 2021, then slipped by 5.82% to $6.6 million in 2022, then jumped by 103.9% to $13.6 million in 2023, then sank by 45.15% to $7.4 million in 2024, then surged by 101.73% to $15.0 million in 2025.
• Business Quant data shows SOPH's Receivables at $15.0 million in Q4 2025, $8.5 million in Q3 2025, and $9.5 million in Q2 2025.